Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Adriana Borello"'
Autor:
Claudia Alejandra Martin, Lourdes Suárez Villasmil, Adela Sembaj, Fabian Gomez Balangione, Silvia Zunino, Cecilia del Carmen Montes, Adriana Borello, Andres Del Castillo, Maximiliano Zeballos, Norma Teresa Rossi
Publikováno v:
Revista de la Facultad de Ciencias Médicas de Córdoba, Vol 79, Iss 3 (2022)
Introducción: Los síndromes de predisposición hereditaria al cáncer representan un 5-10% de los casos de cáncer, el más estudiado es HBOC producido por mutaciones en los genes BRCA1/2. Objetivos: Describir características clínicas, histopatol
Externí odkaz:
https://doaj.org/article/b6406ad8074744728120738fd69eeed7
Autor:
Claudia Alejandra, Martin, Lourdes, Suárez Villasmil, Adela, Sembaj, Fabian, Gomez Balangione, Silvia, Zunino, Cecilia Del Carmen, Montes, Adriana, Borello, Andres, Del Castillo, Maximiliano, Zeballos, Norma Teresa, Rossi
Publikováno v:
Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina). 79(3)
Hereditary predisposition syndromes to cancer represent 5-10% of cancer cases, the most studied being HBOC produced by mutations in the BRCA1/2 genes.To describe clinical, histopathological and PV characteristics in patients with HBOC in Córdoba, Ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8efa82a8f08fa4d01102d141ffc33766
https://pubmed.ncbi.nlm.nih.gov/36149077
https://pubmed.ncbi.nlm.nih.gov/36149077
Autor:
Ricardo Ryser, Miriam Salguero, Ana Gabriela Sturich, Juan José García, Beatriz Moiraghi, Federico Sackmann, Miriam Bonafe, Adriana Berretta, Ana Lisa Basquiera, E. Palazzo, Néstor W. Soria, José Moreno Barral, Adriana Borello
Publikováno v:
Hematology. 14:323-330
Objective: To determine the prevalence of JAK2 V617F mutation and its clinical correlation in patients with chronic myeloproliferative disorders (CMD): polycythemia vera (PV), essential thrombocythemia (ET) and idiopathic myelofibrosis (IMF). Materia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e7c6d2713049f560342a94b86ab8b2f
https://doi.org/10.1179/102453309x12473408860226
https://doi.org/10.1179/102453309x12473408860226
Autor:
Matias F. Mayoraz, Eduardo C. Noguera, Adriana Borello, Juan C. Mondina, Adelina Jaime, Ana Diller, María Virginia Bürgesser, Rodolfo Avila, E. Palazzo
Publikováno v:
Journal of Clinical Oncology. 31:e170-e172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e09452ea8c48de4a6429f19d21605c
https://doi.org/10.1200/jco.2012.44.0099
https://doi.org/10.1200/jco.2012.44.0099
Autor:
Alejandro Ruiz Lascano, Raquel Kuznitzky, Eduardo Cuestas, Claudio Mainardi, Ricardo Albertini, Adriana Borello, María Kurpis, Ricardo Campana, Emilio Palazzo
Publikováno v:
Medicina (Buenos Aires), Vol 64, Iss 6, Pp 504-508 (2004)
En los últimos años se han realizado considerables esfuerzos para identificar factores de riesgo asociados al incremento en la incidencia de melanoma maligno en la población blanca mundial. En Argentina los datos concernientes a factores de riesgo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::d6684303c45956f689623f4166927522
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802004000600005
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802004000600005
Autor:
Alejandro, Ruiz Lascano, Raquel, Kuznitzky, Eduardo, Cuestas, Claudio, Mainardi, Ricardo, Albertini, Adriana, Borello, María, Kurpis, Ricardo, Campana, Emilio, Palazzo
Publikováno v:
Medicina. 64(6)
Over the past years, considerable effort has been directed toward the identification of risk factors associated with the increasing incidence of cutaneous melanoma in white populations worldwide. Limited data are available from Argentine populations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f1b754d054a9f79b0482e15ea7ec9ba0
https://pubmed.ncbi.nlm.nih.gov/15637827
https://pubmed.ncbi.nlm.nih.gov/15637827
Autor:
C. Martin, A. L. Basquiera, Juan Jesús García, E. Palazzo, V. Riva, Ana Diller, Adriana Borello, P. Calafat
Publikováno v:
Journal of Clinical Oncology. 29:e21037-e21037
e21037 Background: Classical parameters used to define therapy for breast cancer are: tumor size, lymph node compromise, grade, hormone-receptors (HR) and Cerb-2. The literature proposes ki-67 as p...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e202176d58e579317f4bbc1a683950c
https://doi.org/10.1200/jco.2011.29.15_suppl.e21037
https://doi.org/10.1200/jco.2011.29.15_suppl.e21037
Autor:
B. Ricchi, M. Botterón, Juan Jesús García, E. Palazzo, P. Calafat, Adriana Borello, N. Rossi, A. G. Sturich, Ana Diller
Publikováno v:
Journal of Clinical Oncology. 27:e22195-e22195
e22195 Background: The amplification of HER-2 oncogen, located in 17q11.2–12, occurs in 20–30% of invasive breast cancer. Numerical anomalies of chromosome 17 are frequent findings in these patients, during the study of the amplification of HER-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::670e2eec59eec58ee9d28d5175b08ad5
https://doi.org/10.1200/jco.2009.27.15_suppl.e22195
https://doi.org/10.1200/jco.2009.27.15_suppl.e22195
Autor:
Adriana Borello, A. L. Basquiera, A. E. Sturich, L. Figueroa, Juan Jesús García, P. Calafat, E. Palazzo, Ana Diller, N. Rossi
Publikováno v:
Journal of Clinical Oncology. 26:11567-11567
11567 Background: The amplification of gen Her-2 and the concomitant overexpression of the transmembrane protein is found in 15–25% of breast carcinomas. The determination of Her-2 expression is important to predict response to trastuzumab and anth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ae849f5abcbbd412f119ba587798117
https://doi.org/10.1200/jco.2008.26.15_suppl.11567
https://doi.org/10.1200/jco.2008.26.15_suppl.11567